Skip to search formSkip to main contentSkip to account menu

glucagon (1-21)

Known as: glucagon(1-21), glucagon-(1-21)-peptide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Since it has been argued that the spasmolytic effect of glucagon is related to the first 21 N-terminal amino acid residues, and… 
1988
1988
The inhibitory effect of glucagon-(1–21)-peptide on the motility of the stomach and duodenum during radiologic double contrast… 
1986
1986
The effects of glucagon and the glucagon-(1-21)-peptide on the duodenal pressure activity in 12 healthy subjects were studied and… 
1986
1986
The metabolic effects of glucagon leading to hyperglycaemia are well recognised. However, the spasmolytic properties of glucagon…